EP1948792A4 - Conditionally replicating viruses and methods for cancer virotherapy - Google Patents
Conditionally replicating viruses and methods for cancer virotherapyInfo
- Publication number
- EP1948792A4 EP1948792A4 EP05824940A EP05824940A EP1948792A4 EP 1948792 A4 EP1948792 A4 EP 1948792A4 EP 05824940 A EP05824940 A EP 05824940A EP 05824940 A EP05824940 A EP 05824940A EP 1948792 A4 EP1948792 A4 EP 1948792A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- conditionally replicating
- replicating viruses
- cancer virotherapy
- virotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/002—Vectors comprising a special origin of replication system inducible or controllable
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/038918 WO2007050074A1 (en) | 2005-10-28 | 2005-10-28 | Conditionally replicating viruses and methods for cancer virotherapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1948792A1 EP1948792A1 (en) | 2008-07-30 |
EP1948792A4 true EP1948792A4 (en) | 2010-08-04 |
Family
ID=37968085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05824940A Withdrawn EP1948792A4 (en) | 2005-10-28 | 2005-10-28 | Conditionally replicating viruses and methods for cancer virotherapy |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1948792A4 (en) |
JP (1) | JP2009513133A (en) |
AU (1) | AU2005337612A1 (en) |
CA (1) | CA2627638A1 (en) |
WO (1) | WO2007050074A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107349226B (en) | 2014-08-26 | 2020-08-25 | 广州威溶特医药科技有限公司 | Application of alphavirus in preparing anti-tumor medicine |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759394B2 (en) * | 2001-07-26 | 2004-07-06 | Board Of Supervisors Of La. State Un. & Agricultural And Mechanical College | Cancer gene therapy based on translational control of a suicide gene |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030017138A1 (en) * | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
AU4250600A (en) * | 1999-04-21 | 2000-11-02 | Genzyme Corporation | Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
-
2005
- 2005-10-28 CA CA002627638A patent/CA2627638A1/en not_active Abandoned
- 2005-10-28 WO PCT/US2005/038918 patent/WO2007050074A1/en active Application Filing
- 2005-10-28 AU AU2005337612A patent/AU2005337612A1/en not_active Abandoned
- 2005-10-28 EP EP05824940A patent/EP1948792A4/en not_active Withdrawn
- 2005-10-28 JP JP2008537668A patent/JP2009513133A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759394B2 (en) * | 2001-07-26 | 2004-07-06 | Board Of Supervisors Of La. State Un. & Agricultural And Mechanical College | Cancer gene therapy based on translational control of a suicide gene |
Non-Patent Citations (7)
Title |
---|
AHMED A ET AL: "A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P- MAPK-selective mRNA stabilization", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US LNKD- DOI:10.1038/NBT835, vol. 21, no. 7, 1 July 2003 (2003-07-01), pages 771 - 777, XP002977838, ISSN: 1087-0156 * |
DEFATTA ROBERT J ET AL: "A cancer gene therapy approach through translational control of a suicide gene.", CANCER GENE THERAPY JUN 2002 LNKD- PUBMED:12032661, vol. 9, no. 6, June 2002 (2002-06-01), pages 505 - 512, XP002587285, ISSN: 0929-1903 * |
DEFATTA ROBERT J ET AL: "Selective killing of cancer cells based on translational control of a suicide gene", CANCER GENE THERAPY, vol. 9, no. 7, July 2002 (2002-07-01), pages 573 - 578, XP002587284, ISSN: 0929-1903 * |
MATHIS J MICHAEL ET AL: "Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.", THE JOURNAL OF GENE MEDICINE SEP 2006 LNKD- PUBMED:16802401, vol. 8, no. 9, September 2006 (2006-09-01), pages 1105 - 1120, XP002587286, ISSN: 1099-498X * |
See also references of WO2007050074A1 * |
TUXWORTH WILLIAM J JR ET AL: "Regulation of protein synthesis by eIF4E phosphorylation in adult cardiocytes: the consequence of secondary structure in the 5'-untranslated region of mRNA.", THE BIOCHEMICAL JOURNAL 15 FEB 2004 LNKD- PUBMED:14629199, vol. 378, no. Pt 1, 15 February 2004 (2004-02-15), pages 73 - 82, XP002587287, ISSN: 1470-8728 * |
YU D ET AL: "Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter", CANCER GENE THERAPY, vol. 13, no. 1, 29 July 2005 (2005-07-29), pages 32 - 43, XP002587283, ISSN: 0929-1903 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007050074A1 (en) | 2007-05-03 |
AU2005337612A8 (en) | 2008-07-03 |
CA2627638A1 (en) | 2007-05-03 |
EP1948792A1 (en) | 2008-07-30 |
AU2005337612A1 (en) | 2007-05-03 |
JP2009513133A (en) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1723238A4 (en) | Modified oncolytic viruses | |
ZA200900022B (en) | Combining virus checking and replication filtration | |
AP2881A (en) | Enhanced systems and methods for re-induced hyperthermia II | |
IL185280A0 (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
EP2064229A4 (en) | Oncolytic rhabdovirus | |
IL194713A0 (en) | Logical and physical security | |
GB2441491A8 (en) | Wlde area security and method | |
EP1969504A4 (en) | Systems and methods for designing experiments | |
FI2479259T3 (en) | Multi-cryopreserved hepatocytes and methods for their preparation | |
EP1951215A4 (en) | Hydrazone derivatives and uses thereof | |
IL197781A0 (en) | Lyophilization methods and apparatuses | |
IL188928A0 (en) | Indol-3-yl-carbonyl-piperidin and piperazin derivatives | |
EP2170380A4 (en) | Capsid proteins and uses therefore | |
ZA200705280B (en) | Cancer markers and detection methods | |
GB0416487D0 (en) | Modified virus | |
EP1948792A4 (en) | Conditionally replicating viruses and methods for cancer virotherapy | |
EP2068848A4 (en) | Enhanced broad-spectrum uv radiation filters and methods | |
GB0501884D0 (en) | Document creation system and related methods | |
GB0619245D0 (en) | Astrological and numerological classification | |
GB2448603B (en) | Copy-protected documents | |
GB0501886D0 (en) | Document creation system and related methods | |
ZA200800523B (en) | Indol-3-yl-carbonyl-piperidin and piperazin derivatives | |
GB0522684D0 (en) | Oncolytic viruses | |
GB0622190D0 (en) | Oncolytic viruses | |
GB2422738B (en) | Document creation system and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080423 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100706 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20100804 |